NATH BIOGENES (INDIA)
Back to Cashflow Statement
|
NATH BIOGENES (INDIA) Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2013 | Mar2012 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹75 Cr | ₹38 Cr | ₹17 Cr | ₹14 Cr | - |
What is the latest Cash Flow from Operating Activities ratio of NATH BIOGENES (INDIA) ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2024 | ₹75 Cr |
Mar2023 | ₹38 Cr |
Mar2022 | ₹17 Cr |
Mar2013 | ₹14 Cr |
Mar2012 | - |
How is Cash Flow from Operating Activities of NATH BIOGENES (INDIA) Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2024 | ₹75 Cr | 94.42 | |
Mar2023 | ₹38 Cr | 125.05 | |
Mar2022 | ₹17 Cr | 19.96 | |
Mar2013 | ₹14 Cr | 0 | |
Mar2012 | - | - |
Compare Cash Flow from Operating Activities of peers of NATH BIOGENES (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATH BIOGENES (INDIA) | ₹286.3 Cr | -6.4% | -10.1% | -25% | Stock Analytics | |
BOMBAY BURMAH TRADING CORPORATION | ₹11,592.2 Cr | -9.5% | -21.2% | -0.4% | Stock Analytics | |
KAVERI SEED COMPANY | ₹5,148.0 Cr | 2.1% | 11% | 55.9% | Stock Analytics | |
VENKYS (INDIA) | ₹2,301.8 Cr | -1.3% | -9.9% | -9.1% | Stock Analytics | |
BOMBAY SUPER HYBRID SEEDS | ₹1,405.4 Cr | -7% | -12.6% | -38.5% | Stock Analytics | |
INDO US BIOTECH | ₹394.8 Cr | -9.8% | -10.3% | -14.4% | Stock Analytics |
NATH BIOGENES (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATH BIOGENES (INDIA) | -6.4% |
-10.1% |
-25% |
SENSEX | -3.4% |
-4.4% |
0.6% |
You may also like the below Video Courses